CAS 285983-48-4 appears in our catalog under these names: Doramapimod, BIRB 796 (Doramapimod), Doramapimod/ 99.65% (existing batch purity), Doramapimod, >98.0%(HPLC)(T), Doramapimod 99%. Offered by: TRC, GLPBio, TargetMol, Biosynth, TCI. Available pack sizes: 10mg, 100mg, 5mg, 10mM (in 1ml dmso), 50mg, 1g, 25mg, 200mg.
Doramapimod is a member of the class of pyrazoles that is an immunomodulator used for treatment of rheumatoid arthritis, Crohn's disease and psoriasis. It has a role as an immunomodulator and an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of naphthalenes, a member of pyrazoles, an aromatic ether, a member of morpholines and a member of ureas.
Source: ChEBI
| Molecular formula | C31H37N5O3 |
|---|---|
| Molecular weight | 527.7 g/mol |
| IUPAC name | 1-[3-tert-butyl-1-(4-methylphenyl)pyrazol-5-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea |
| InChIKey | MVCOAUNKQVWQHZ-UHFFFAOYSA-N |
| SMILES | CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5 |
Computed by PubChem (NCBI)